Foreign Filer Report • May 10, 2017
Foreign Filer Report
Open in ViewerOpens in native device viewer
For the month of May, 2017 _________________
Commission File Number: 001-13742
(Exact name of registrant as specified in its charter)
Israel Chemicals Ltd. Millennium Tower 23 Aranha Street P.O. Box 20245 Tel Aviv, 61202 Israel (972-3) 684-4400 (Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
| Yes | No | X |
|---|---|---|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes No X
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333- 205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.


| March 31, 2017March 31, 2016 December 31, | 2016 | ||
|---|---|---|---|
| \$ millions | \$ millions | \$ millions | |
| Current assets | |||
| Cash and cash equivalents | 81 | 123 | 87 |
| Short-term investments and deposits | 38 | 89 | 29 |
| Trade receivables | 968 | 969 | 966 |
| Inventories | 1,248 | 1,444 | 1,267 |
| Assets held for sale | 122 | 10 | - |
| Other receivables | 247 | 296 | 222 |
| Total current assets | 2,704 | 2,931 | 2,571 |
| Non-current assets | |||
| Investments in equity-accounted investees | 31 | 148 | 153 |
| Financial assets available for sale | 240 | 268 | 253 |
| Deferred tax assets | 144 | 131 | 150 |
| Property, plant and equipment | 4,349 | 4,288 | 4,309 |
| Intangible assets | 829 | 1,219 | 824 |
| Other non-current assets | 336 | 318 | 292 |
| Total non-current assets | 5,929 | 6,372 | 5,981 |
| Total assets | 8,633 | 9,303 | 8,552 |
| Current liabilities | |||
| Short-term credit | 590 | 683 | 588 |
| Trade payables | 695 | 717 | 644 |
| Provisions | 92 | 50 | 83 |
| Other current liabilities | 701 | 655 | 708 |
| Total current liabilities | 2,078 | 2,105 | 2,023 |
| Non-current liabilities | |||
| Long-term debt and debentures | 2,791 | 2,960 | 2,796 |
| Deferred tax liabilities | 305 | 296 | 303 |
| Long-term employee provisions | 595 | 576 | 576 |
| Provisions | 174 | 129 | 185 |
| Other non-current liabilities | 9 | 23 | 10 |
| Total non-current liabilities | 3,874 | 3,984 | 3,870 |
| Total liabilities | |||
| 5,952 | 6,089 | 5,893 | |
| Equity | |||
| Total shareholders' equity | 2,603 | 3,061 | 2,574 |
| Non-controlling interests | 78 | 153 | 85 |
| Total equity | 2,681 | 3,214 | 2,659 |
| Total liabilities and equity | |||
| 8,633 | 9,303 | 8,552 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
(in millions except per share data)
| For the three-month period ended March 31, 2017March 31, 2016 December 31, |
For the year ended 2016 |
||
|---|---|---|---|
| \$ millions | \$ millions | \$ millions | |
| Sales | 1,295 | 1,265 | 5,363 |
| Cost of sales | 937 | 899 | 3,703 |
| Gross profit | 358 | 366 | 1,660 |
| Selling, transport and marketing expenses | 180 | 155 | 722 |
| General and administrative expenses | 66 | 80 | 321 |
| Research and development expenses | 15 | 17 | 73 |
| Other expenses | - | 10 | 618 |
| Other income | (19) | (3) | (71) |
| Operating income (loss) | 116 | 107 | (3) |
| Finance expenses | 91 | 42 | 157 |
| Finance income | (77) | (14) | (25) |
| Finance expenses, net | 14 | 28 | 132 |
| Share in earnings of equity-accounted investees | 1 | 2 | 18 |
| Income (loss) before income taxes | 103 | 81 | (117) |
| Income taxes | 42 | 22 | 55 |
| Net income (loss) | 61 | 59 | (172) |
| Net loss attributable to the non-controlling interests | (7) | (7) | (50) |
| Net income (loss) attributable to the shareholders of the Company | 68 | 66 | (122) |
| Earnings (loss) per share attributable to the shareholders of the Company: |
|||
| Basic earnings (loss) per share (in cents) | 5.30 | 5.20 | (10.00) |
| Diluted earnings (loss) per share (in cents) | 5.30 | 5.20 | (10.00) |
| Weighted-average number of ordinary shares outstanding: |
|||
| Basic (in thousands) | 1,276,098 | 1,272,930 | 1,273,295 |
| Diluted (in thousands) | 1,276,975 | 1,273,499 | 1,273,295 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| For the three-month period ended March 31, 2017March 31, 2016 December 31, |
For the year ended 2016 |
||
|---|---|---|---|
| \$ millions | \$ millions | \$ millions | |
| Net income (loss) | 61 | 59 | (172) |
| Components of other comprehensive income that will be reclassified subsequently to net income (loss) |
|||
| Currency translation differences | 30 | 48 | (90) |
| Changes in fair value of derivatives designated as a cash flow hedge | - | (1) | (1) |
| Changes in fair value of financial assets available for sale Income (loss) tax relating to items that will be reclassified subsequently to net |
(15) | 13 | 17 |
| income (loss) | 4 | (3) | (5) |
| Total | 19 | 57 | (79) |
| Components of other comprehensive income that will not be reclassified to net income (loss) |
|||
| Actuarial losses from defined benefit plan | (4) | (19) | (48) |
| Income tax relating to items that will not be reclassified to net income (loss) | 1 | 6 | 8 |
| Total | (3) | (13) | (40) |
| Total comprehensive income (loss) | 77 | 103 | (291) |
| Comprehensive loss attributable to the non-controlling interests | (7) | (7) | (59) |
| Comprehensive income (loss) attributable to the shareholders of the Company |
84 | 110 | (232) |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| For the three-month period ended |
For the year ended 2016 |
||
|---|---|---|---|
| March 31, 2017March 31, 2016 December 31, | |||
| \$ millions | \$ millions | \$ millions | |
| Cash flows from operating activities | |||
| Net income (loss) | 61 | 59 | (172) |
| Adjustments for: | |||
| Depreciation and amortization | 94 | 99 | 406 |
| Revaluation of balances from financial institutions and interest expenses, net | 57 | 29 | 76 |
| Share in earnings of equity-accounted investees, net | (1) | (2) | (18) |
| Other capital losses (gains), net | (9) | 1 | 433 |
| Share-based compensation | 2 | 5 | 15 |
| Deferred tax expenses (income) | 13 | (5) | (2) |
| 217 | 186 | 738 | |
| Change in inventories | 28 | (57) | 70 |
| Change in trade and other receivables | (23) | 114 | 150 |
| Change in trade and other payables | (32) | (36) | (90) |
| Change in provisions and employee benefits | 5 | 15 | 98 |
| Net change in operating assets and liabilities | (22) | 36 | 228 |
| Net cash provided by operating activities | 195 | 222 | 966 |
| Cash flows from investing activities | |||
| Investments in shares and proceeds from deposits, net | (10) | (249) | (198) |
| Purchases of property, plant and equipment and intangible assets | (106) | (187) | (632) |
| Proceeds from divestiture of subsidiaries | - | 17 | 17 |
| Other | 15 | (1) | 13 |
| Net cash used in investing activities | (101) | (420) | (800) |
| Cash flows from financing activities | |||
| Dividend paid to the company's shareholders | (60) | - | (162) |
| Receipt of long-term debt | 420 | 400 | 1,278 |
| Repayment of long-term debt | (425) | (250) | (1,365) |
| Short-term credit from banks and others, net | (36) | 7 | 14 |
| Other | - | - | (4) |
| Net cash provided by (used in) financing activities | (101) | 157 | (239) |
| Net change in cash and cash equivalents | (7) | (41) | (73) |
| Cash and cash equivalents as at beginning of the year | 87 | 161 | 161 |
| Net effect of currency translation on cash and cash equivalents | 1 | 3 | (1) |
| Cash and cash equivalents as at the end of the period | 81 | 123 | 87 |
| For the three-month period ended March 31, 2017March 31, 2016 December 31, |
|||
|---|---|---|---|
| \$ millions | \$ millions | \$ millions | |
| Income taxes paid, net of tax refunds | 21 | 36 | 84 |
| Interest paid | 21 | 16 | 112 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| Attributable to the shareholders of the Company | Non controlling interests |
Total equity |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Cumulative translation adjustments |
Capital reserves |
Treasury shares, at cost |
Retained earnings |
Total shareholders' equity |
|||
| \$ millions | |||||||||
| For the three-month period ended March 31, 2017 |
|||||||||
| Balance as at January 1, 2017 | 544 | 174 | (481) | 79 | (260) | 2,518 | 2,574 | 85 | 2,659 |
| Share-based compensation Dividends Comprehensive income (loss) |
- - - |
- - - |
- - 30 |
2 - (11) |
- - - |
- (57) 65 |
2 (57) 84 |
- - (7) |
2 (57) 77 |
| Balance as at March 31, 2017 | 544 | 174 | (451) | 70 | (260) | 2,526 | 2,603 | 78 | 2,681 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| Attributable to the shareholders of the Company | Non- controlling interests |
Total equity |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Cumulative translation adjustments |
Capital reserves |
Treasury shares, at cost |
Retained earnings |
Total shareholders' equity |
|||
| \$ millions | |||||||||
| For the three-month period ended March 31, 2016 |
|||||||||
| Balance as at January 1, 2016 | 544 | 149 | (400) | 93 | (260) | 2,902 | 3,028 | 160 | 3,188 |
| Share-based compensation Dividends |
- - |
1 - |
- - |
4 - |
- - |
- (67) |
5 (67) |
- - |
5 (67) |
| Changes in equity of equity-accounted investees |
- | - | - | (15) | - | - | (15) | - | (15) |
| Comprehensive income (loss) | - | - | 48 | 9 | - | 53 | 110 | (7) | 103 |
| Balance as at March 31, 2016 | 544 | 150 | (352) | 91 | (260) | 2,888 | 3,061 | 153 | 3,214 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| Attributable to the shareholders of the Company controlling interests |
Total equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Cumulative translation adjustments |
Capital reserves |
Treasury shares, at cost |
Retained earnings |
Total shareholders' equity |
|||
| \$ millions | |||||||||
| For the year ended December 31, 2016 |
|||||||||
| Balance as at January 1, 2016 | 544 | 149 | (400) | 93 | (260) | 2,902 | 3,028 | 160 | 3,188 |
| Share-based compensation | - * | 25 | - | (10) | - | - | 15 | - | 15 |
| Dividends Changes in equity of equity-accounted |
- | - | - | - | - | (222) | (222) | (4) | (226) |
| investees | - | - | - | (15) | - | - | (15) | - | (15) |
| Non-controlling interests in business combinations from prior periods |
- | - | - | - | - | - | - | (12) | (12) |
| Comprehensive loss | - | - | (81) | 11 | - | (162) | (232) | (59) | (291) |
| Balance as at December 31, 2016 | 544 | 174 | (481) | 79 | (260) | 2,518 | 2,574 | 85 | 2,659 |
* Less than \$1 million.
The accompanying notes are an integral part of these condensed consolidated financial statements.
Israel Chemicals Ltd. (hereinafter – the Company or ICL), is a leading global specialty minerals group that operates a unique, integrated business model.
ICL is a global manufacturer of products based on specialty minerals that fulfill humanity's essential needs in three primary markets: agriculture, food and engineered materials, by utilizing a unique, integrated business model.
The agricultural products produced by ICL help to feed the world's growing population. The potash and phosphates ICL mines and manufactures are used as ingredients in fertilizers and serve as an essential component in the pharmaceutical and food additives industries. ICL's bromine-based and phosphorous-based applications allow the safe and widespread use of a variety of products and materials, help to create energy that is more efficient and environmentally friendly and prevent the spread of forest fires. The food additives that ICL produces enable greater access to more varied and higher quality food.
ICL is a company domiciled and incorporated in Israel, the shares of which are traded on the Tel-Aviv Stock Exchange in Israel and on the New York Stock Exchange ("NYSE") in the United States. The Company's main shareholder is Israel Corporation Ltd.
The Company's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board (IASB) and the Company uses IFRS as its generally accepted accounting principles ("GAAP").
The condensed consolidated interim financial statements were prepared in accordance with IAS 34, "Interim Financial Reporting" and do not include all the information required in complete, annual financial statements. These condensed consolidated interim financial statements and notes are unaudited and should be read together with the Company's audited financial statements included in its Annual Report on Form 20-F as at and for the year ended December 31, 2016 (hereinafter – the Annual Financial Statements), as filed with the Securities and Exchange Commission ("SEC").
The accounting policies and assumptions used in preparation of these condensed consolidated interim financial statements are consistent with those used in preparation of the Company's Annual Financial Statements and in the Company's opinion include all the adjustments necessary to fairly present such information. Interim results are not necessarily indicative of the Company's expected results for the entire year.
ICL is a leading global specialty minerals company that operates a unique integrated business model. The Company operates via two segments: the Essential Minerals Segment and the Specialty Solutions Segment, which constitute the Company's strategic business segments.
Essential Minerals Segment – This segment includes three business lines: ICL Potash & Magnesium, ICL Phosphate and, since January 2017, also ICL Specialty Fertilizers. The comparative data has been restated in order to reflect the change. The segment targets the Agro market and focuses on efficiency, process innovation and operational excellence, in order to improve the competitive position.
ICL Potash & Magnesium – ICL Potash & Magnesium extracts potash from the Dead Sea and mines and produces potash and salt from subterranean mines in Spain and the UK. ICL Potash & Magnesium processes the potash into its types and markets it globally and also carries on other intercompany operations not solely related to the potash activities. The Company also mines and produces polysulphate (also known as polyhalite) in a subterranean mine in the UK. The magnesium business markets and sells pure magnesium and magnesium alloys, and also produces dry carnallite and related by-products, including chlorine and sylvinite.
ICL Phosphate – ICL Phosphate mines and processes phosphate rock from open pit mines – three of which are located in the Negev Desert in Israel while the fourth is situated in the Yunnan province in China. In addition, ICL Phosphate produces sulfuric acid, agricultural phosphoric acid and phosphate fertilizers in its facilities in Israel, China and Europe. Furthermore, ICL Phosphate manufactures phosphate-based food additives for livestock in Turkey. ICL Phosphate markets its products worldwide, mainly in Europe, Brazil, India and China.
ICL Specialty Fertilizers – ICL Specialty Fertilizers produces specialty fertilizers (e.g., water soluble) in the Netherlands and Belgium, liquid fertilizers and soluble fertilizers in Israel and Spain and controlled-release fertilizers in the Netherlands and the United States. ICL Specialty Fertilizers markets its products worldwide, mainly in Europe, North America and Israel.
Specialty Solutions Segment – This segment includes three business lines: ICL Industrial Products, ICL Advanced Additives and ICL Food Specialties. The segment targets industrial markets and concentrates on achieving growth through a highly-tailored customer focus, product innovation and commercial excellence.
ICL Industrial Products – ICL Industrial Products produces bromine out of a solution that is created as a by-product of the potash production process in Sodom, Israel, as well as bromine-based compounds. ICL Industrial Products uses most of the bromine it produces for self-production of bromine compounds at production sites in Israel, the Netherlands and China. In addition, ICL Industrial Products is engaged in the production and marketing of phosphorous flame retardants and additional phosphorus-based products.
ICL Advanced Additives – ICL Advanced Additives primarily develops, produces, markets and sells a broad range of acids, specialty phosphates and specialty minerals for various applications in a large number of industries, including metal and water treatment, paints and coatings, forest fire retardants, cleaning materials, oral hygiene, carbonated drinks, asphalt modification, de-icing, nutrition, pharma, specialty steel, fuel additives and rubber. The diverse products and market base supports and is consistent with the Company's strategy of increasing production of downstream products with higher added value. ICL Advanced Additives purifies some of the agricultural phosphoric acid manufactured by ICL Phosphate and also manufactures thermal phosphoric acid. The purified phosphoric acid and the thermal phosphoric acid are used to manufacture downstream products with high added value – phosphate salts and acids – which are used in the various industries mentioned above. The product line of ICL Advanced Additives is further comprised of processed potassium, calcium and magnesium products used in the pharma, specialty steel, oil drilling, and oil additives industries, along with de-icing and other applications.
ICL Food Specialties – ICL Food Specialties is a leader in developing and producing functional food ingredients and phosphate additives, which provide texture and stability solutions for the processed meat, fish, dairy, beverage and baked-goods markets. In addition, the business line produces milk proteins and whey proteins for the food ingredient industry and provides blended, integrated solutions based on dairy proteins and phosphate additives. The business line operates primary production locations in Germany and Austria, which mainly process phosphates, milk and spices, and runs several local blending facilities in Germany, the UK, the United States, Brazil, China and Australia, enabling the production of "customer specific" solutions that meet the requirements of the local market.
The capital investments made by the segments, for each of the reporting periods, include mainly property, plant and equipment and intangible assets acquired in the ordinary course of business and as part of business combinations.
Segment revenues, expenses and results include inter-segment transfers, which are priced based on transaction prices in the ordinary course of business. These transfers are eliminated as part of consolidation of the financial statements. The segment income is measured based on the operating income, without certain expenses that are not allocated to the operating segments including general and administrative expenses, as it is included in reports that are regularly reviewed by the chief operating decision maker.
$$\mathbf{0}$$
| Specialty Solutions Segment |
Essential Minerals Segment |
Other activities |
Eliminations Consolidated | ||
|---|---|---|---|---|---|
| \$ millions | |||||
| For the three-month period ended March 31, 2017 | |||||
| Sales to external parties | 599 | 686 | 10 | - | 1,295 |
| Inter-segment sales | 14 | 48 | 1 | (63) | - |
| Total sales | 613 | 734 | 11 | (63) | 1,295 |
| Operating income attributed to segments | 115 | 66 | - | 181 | |
| General and administrative expenses | (66) | ||||
| Other unallocated expenses and intercompany eliminations Operating income |
1 116 |
||||
| Financing expenses, net | (14) | ||||
| Share in earnings of equity-accounted investee | 1 | ||||
| Income before taxes on income | 103 | ||||
| Capital expenditures | 12 | 99 | - | 111 | |
| Capital expenditures not allocated | 1 | ||||
| Total capital expenditures | 112 | ||||
| Depreciation and amortization | 28 | 65 | 1 | 94 | |
| Depreciation and amortization not allocated | - * | ||||
| Total depreciation and amortization | 94 | ||||
* Less than \$1 million.
| Specialty Solutions Segment |
Essential Minerals Segment |
Other activities |
Eliminations Consolidated | ||
|---|---|---|---|---|---|
| \$ millions | |||||
| For the three-month period ended March 31, 2016 | |||||
| Sales to external parties | 570 | 670 | 25 | - | 1,265 |
| Inter-segment sales | 14 | 53 | - | (67) | - |
| Total sales | 584 | 723 | 25 | (67) | 1,265 |
| Operating income attributed to segments | 106 | 93 | 2 | 201 | |
| General and administrative expenses | (80) | ||||
| Other unallocated expenses and intercompany eliminations | (14) | ||||
| Operating income | 107 | ||||
| Financing expenses, net | (28) | ||||
| Share in earnings of equity-accounted investee | 2 | ||||
| Income before taxes on income | 81 | ||||
| Capital expenditures | 25 | 123 | 1 | 149 | |
| Capital expenditures not allocated | 14 | ||||
| Total capital expenditures | 163 | ||||
| Depreciation and amortization | 26 | 73 | - | 99 | |
| Depreciation and amortization not allocated | - * | ||||
| Total depreciation and amortization | 99 | ||||
| * Less than \$1 million. |
| Specialty Solutions Segment |
Essential Minerals Segment |
Other activities |
Eliminations Consolidated | ||
|---|---|---|---|---|---|
| \$ millions | |||||
| For the year ended December 31, 2016 | |||||
| Sales to external parties Inter-segment sales Total sales |
2,493 60 2,553 |
2,811 225 3,036 |
59 - 59 |
- (285) (285) |
5,363 - 5,363 |
| Operating income attributed to segments General and administrative expenses Other unallocated expenses and intercompany eliminations Operating loss |
534 | 398 | 5 | 937 (321) (619) (3) |
|
| Financing expenses, net Share in earnings of equity-accounted investee Loss before taxes on income |
(132) 18 (117) |
||||
| Capital expenditures Capital expenditures not allocated Total capital expenditures |
95 | 497 | 1 | 593 59 652 |
|
| Depreciation and amortization Depreciation and amortization not allocated Total depreciation and amortization |
106 | 292 | 3 | 401 5 406 |
|
| 1-3/2017 | 1-3/2016 | 2016 | ||||
|---|---|---|---|---|---|---|
| \$ | % of | \$ | % of | \$ | % of | |
| millions | sales | millions | sales | millions | sales | |
| Specialty Solutions Segment | ||||||
| Industrial Products | 266 | 21 | 224 | 18 | 953 | 18 |
| Advanced Additives | 213 | 16 | 208 | 16 | 966 | 18 |
| Food Specialties | 138 | 11 | 162 | 13 | 659 | 12 |
| 617 | 48 | 594 | 47 | 2,578 | 48 | |
| Essential Minerals Segment | ||||||
| Phosphate | 292 | 22 | 299 | 23 | 1,163 | 22 |
| Potash & Magnesium | 283 | 22 | 273 | 22 | 1,338 | 25 |
| Specialty Fertilizers | 192 | 15 | 188 | 15 | 661 | 12 |
| 767 | 59 | 760 | 60 | 3,162 | 59 | |
| Other and setoffs | (89) | (7) | (89) | (7) | (377) | (7) |
| Total | 1,295 | 100 | 1,265 | 100 | 5,363 | 100 |
| 1-3/2017 | 1-3/2016 | 2016 | ||||
|---|---|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
|
| Europe | 534 | 41 | 559 | 44 | 1,863 | 35 |
| North America | 294 | 23 | 267 | 21 | 1,141 | 21 |
| Asia | 282 | 22 | 239 | 19 | 1,275 | 24 |
| South America | 98 | 8 | 92 | 7 | 588 | 11 |
| Rest of the world | 87 | 6 | 108 | 9 | 496 | 9 |
| Total | 1,295 | 100 | 1,265 | 100 | 5,363 | 100 |
| 1-3/2017 | 1-3/2016 | 2016 | ||||
|---|---|---|---|---|---|---|
| \$ | % of | \$ | % of | \$ | % of | |
| millions | sales | millions | sales | millions | sales | |
| USA | 276 | 21 | 253 | 20 | 1,070 | 20 |
| China | 145 | 11 | 108 | 9 | 669 | 13 |
| Germany | 98 | 8 | 112 | 9 | 392 | 7 |
| United Kingdom | 89 | 7 | 98 | 8 | 306 | 6 |
| Spain | 79 | 6 | 75 | 6 | 258 | 5 |
| Brazil | 77 | 6 | 77 | 6 | 521 | 10 |
| France | 71 | 5 | 71 | 6 | 226 | 4 |
| Israel | 52 | 4 | 53 | 4 | 237 | 4 |
| Italy | 40 | 3 | 40 | 3 | 122 | 2 |
| India | 37 | 3 | 26 | 2 | 199 | 4 |
| All other | 331 | 26 | 352 | 27 | 1,363 | 25 |
| Total | 1,295 | 100 | 1,265 | 100 | 5,363 | 100 |
The carrying amounts of certain financial assets and financial liabilities, including cash and cash equivalents, investments, short-term deposits and loans, receivables and other debit balances, long-term investments and receivables, short-term credit, payables and other credit balances, long-term loans bearing variable interest and other liabilities, and derivative financial instruments, correspond to or approximate their fair value.
The following table details the book value and fair value of financial instrument groups presented in the financial statements not in accordance with their fair value:
| March 31, 2017 | March 31, 2016 | December 31, 2016 | |||||
|---|---|---|---|---|---|---|---|
| Carrying amount |
Fair value | Carrying amount |
Fair value | Carrying amount |
Fair value | ||
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | ||
| Loans bearing fixed interest | 285 | 298 | 385 | 408 | 293 | 306 | |
| Debentures bearing fixed interest |
|||||||
| Marketable | 1,232 | 1,236 | 802 | 807 | 1,201 | 1,201 | |
| Non-marketable | 278 | 279 | 278 | 291 | 281 | 283 | |
| 1,795 | 1,813 | 1,465 | 1,506 | 1,775 | 1,790 | ||
The following table presents an analysis of the financial instruments measured at fair value, using a valuation method in accordance with the fair value levels in the hierarchy.
Levels definitions:
Level 1: Quoted (unadjusted) prices in an active market for identical instruments.
Level 2: Observed data in the market (directly or indirectly) not included in Level 1 above.
Level 3: Inputs that are not based on observable market data.
| March 31, 2017 | |||||
|---|---|---|---|---|---|
| Level 2 | Level 3 | Total | |||
| \$ millions | \$ millions | \$ millions | |||
| Financial assets available for sale (1) | - | 240 | 240 | ||
| Derivatives used for economic hedging, net | 51 | - | 51 | ||
| 51 | 240 | 291 |
| March 31, 2016 | |||||
|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | ||
| \$ millions | \$ millions | \$ millions | \$ millions | ||
| Securities held for trading purposes | 26 | - | - | 26 | |
| Financial assets available for sale (1) | - | - | 268 | 268 | |
| Derivatives used for economic hedging, net | - | (11) | - | (11) | |
| 26 | (11) | 268 | 283 |
| December 31, 2016 | |||
|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total |
| \$ millions | \$ millions | \$ millions | \$ millions |
| 10 | |||
| - | - | 253 | 253 |
| - | 7 | - | 7 |
| 10 | 7 | 253 | 270 |
| 10 | - | - |
(1) Investment in 15% of the share capital of YTH, which is subject to a three-year lock-up period as required by Chinese law. Measurement of the fair value of the discount rate in respect of the lock-up period was calculated by use of the Finnerty 2012 Model and is based on an estimate of the period in which the restriction on marketability applies and a standard deviation of the yield on a YTH share in this period. The impact stemming from a possible and reasonable change in these data items, which are not observed, is not material.
| Decision date for dividend distribution by the Board of Directors |
Actual date of dividend distribution |
Distributed amount (\$ millions) |
Dividend per share (\$) |
|---|---|---|---|
| November 22, 2016 | January 4, 2017 | 60 | 0.04701 |
| February 14, 2017 | April 4, 2017 | 57 | 0.04400 |
| May 9, 2017 (after the date of the report)* | June 20, 2017 | 34 | 0.02600 |
(*) The dividend will be distributed on June 20, 2017, with a record date for eligibility for the dividend of June 6, 2017.
In addition, in March 2017, the Supreme Court sitting as the High Court of Justice rejected the petition of residents of Arad against the policy document of the National Council for Planning and Building regarding the mining plan in Barir field.
Notes to the condensed consolidated interim financial statements as at March 31, 2017 (Unaudited)


This announcement contains statements that constitute "forward-looking statements", many of which can be identified by the use of forward-looking words such as "anticipate'", "believe", "could", "expect", "should", "plan", "intend", "estimate" and "potential", among others.
Forward-looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are based on our management's beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward- looking statements due to various factors, including, but not limited to:
Loss or impairment of business licenses or mining permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and our reserve estimates; natural disasters; failure to raise the water level in evaporation Pond 5 in the Dead Sea; construction of a new pumping station; disruptions at our seaport shipping facilities or regulatory restrictions affecting our ability to export our products overseas; general market, political or economic conditions in the countries in which we operate; price increases or shortages with respect to our principal raw materials; delays in the completion of major projects by third party contractors and/or governmental obligations; construction of a canal between the Red Sea and Dead Sea; labor disputes, slowdowns and strikes involving our employees; pension and health insurance liabilities; changes to governmental programs or tax benefits, creation of new fiscal or tax related legislation; higher tax liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of our information technology systems or breaches of our data security; failure to recruit or maintain key personnel; inability to realize expected benefits from our cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of our businesses; changes in demand for our fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond our control; decreases in demand for bromine based products and other industrial products; volatility or crises in the financial markets; cost of compliance with environmental legislative and licensing restrictions; hazards inherent to chemical manufacturing; litigation, arbitration and regulatory proceedings; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror; and other risk factors discussed under "Item 3. Key Information—D. Risk Factors" in the company's Annual Report on Form 20-F filed with the U.S Securities and Exchange Commission on March 16, 2017.
Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update or revise them or any other information contained in this report, whether as a result of new information, future developments or otherwise. You are advised, however, to read any additional disclosures included in the Immediate Reports furnished by the Company to the SEC on Form 6-K.
We are a leading global specialty minerals company that operates a unique, integrated business model. We extract raw materials and utilize sophisticated processing and product formulation technologies to add value to customers in three attractive end-markets: agriculture, food and engineered materials. Our operations are organized under two segments: the Essential Minerals Segment and the Specialty Solutions Segment. The Essential Minerals Segment includes three business lines: ICL Potash & Magnesium, ICL Phosphate and ICL Specialty Fertilizers. The Specialty Solutions Segment includes three business lines: ICL Industrial Products, ICL Advanced Additives and ICL Food Specialties.
Our operations are organized under two segments: the Essential Minerals Segment and the Specialty Solutions Segment.
Essential Minerals Segment – This segment targets the Agro markets and focuses on efficiency, process innovation and operational excellence, in order to improve its competitive position. The segment includes three business lines: ICL Potash & Magnesium, ICL Phosphate and, since January 2017, also ICL Specialty Fertilizers. Management believes that operating ICL Specialty Fertilizers as part of the Essential Minerals segment is expected to create synergies given the homogenous business and customer bases of the segment's three business lines. Furthermore, the transfer expands the segment's portfolio to include a broader range of commodity, specialty and semi-specialty products. As a result, the comparative data has been restated in order to reflect the mentioned above change.
ICL Potash & Magnesium – ICL Potash & Magnesium extracts potash from the Dead Sea and mines and produces potash and salt from subterranean mines in Spain and the UK. ICL Potash & Magnesium processes the potash into its types and markets it globally and also carries on other intercompany operations not solely related to the potash activities. The Company also mines and produces polysulphate (also known as polyhalite) in a subterranean mine in the UK. The magnesium business markets and sells pure magnesium and magnesium alloys, and also produces dry carnallite and related by-products, including chlorine and sylvinite.
ICL Phosphate – ICL Phosphate mines and processes phosphate rock from open pit mines – three of which are located in the Negev Desert in Israel while the fourth is situated in the Yunnan province in China. In addition, ICL Phosphate produces sulfuric acid, agricultural phosphoric acid and phosphate fertilizers in its facilities in Israel, China and Europe. Furthermore, ICL Phosphate manufactures phosphate-based food additives for livestock in Turkey. ICL Phosphate markets its products worldwide, mainly in Europe, Brazil, India and China.
ICL Specialty Fertilizers – ICL Specialty Fertilizers produces specialty fertilizers (e.g., water soluble) in the Netherlands and Belgium, liquid fertilizers and soluble fertilizers in Israel and Spain, and controlled-release fertilizers in the Netherlands and the United States. ICL Specialty Fertilizers markets its products worldwide, mainly in Europe, North America and Israel.
$$^{20}$$
Specialty Solutions Segment – This segment targets industrial markets and concentrates on achieving growth through a highly-tailored customer focus, product innovation and commercial excellence. The segment includes three business lines: ICL Industrial Products, ICL Advanced Additives and ICL Food Specialties.
ICL Industrial Products – ICL Industrial Products produces bromine out of a solution that is created as a by-product of the potash production process in Sodom, Israel, as well as bromine-based compounds. ICL Industrial Products uses most of the bromine it produces for self-production of bromine compounds at production sites in Israel, the Netherlands and China. In addition, ICL Industrial Products is engaged in the production and marketing of phosphorous flame retardants and additional phosphorus-based products.
ICL Advanced Additives – ICL Advanced Additives primarily develops, produces, markets and sells a broad range of acids, specialty phosphates and specialty minerals for various applications in a large number of industries, including metal and water treatment, paints and coatings, forest fire retardants, cleaning materials, oral hygiene, carbonated drinks, asphalt modification, de-icing, nutrition, pharma, specialty steel, fuel additives and rubber. The diverse products and market base supports and is consistent with the Company's strategy of increasing production of downstream products with higher added value. ICL Advanced Additives purifies some of the agricultural phosphoric acid manufactured by ICL Phosphate and also manufactures thermal phosphoric acid. The purified phosphoric acid and the thermal phosphoric acid are used to manufacture downstream products with high added value – phosphate salts and acids – which are used in the various industries mentioned above. The product line of ICL Advanced Additives is further comprised of processed potassium, calcium and magnesium products used in the pharma, specialty steel, oil drilling, and oil additives industries, along with de-icing and other applications.
ICL Food Specialties – ICL Food Specialties is a leader in developing and producing functional food ingredients and phosphate additives, which provide texture and stability solutions for the processed meat, fish, dairy, beverage and baked goods markets. In addition, the business line produces milk proteins and whey proteins for the food ingredient industry and provides blended, integrated solutions based on dairy proteins and phosphate additives. The business line operates primary production locations in Germany and Austria, which mainly process phosphates, milk and spices, and runs several local blending facilities in Germany, the UK, the United States, Brazil, China and Australia, enabling the production of "customer specific" solutions that meet the requirements of the local market.
| 1-3/2017 | 1-3/2016 | 2016 | ||||
|---|---|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
|
| Sales | 1,295 | - | 1,265 | - | 5,363 | - |
| Gross profit | 358 | 28 | 366 | 29 | 1,660 | 31 |
| Operating income (loss) | 116 | 9 | 107 | 8 | (3) | - |
| Adjusted operating income | 116 | 9 | 115 | 9 | 582 | 11 |
| Net income (loss) - shareholders of the Company | 68 | 5 | 66 | 5 | (122) | - |
| Adjusted net income - shareholders of the Company | 68 | 5 | 85 | 7 | 451 | 8 |
| Adjusted EBITDA (1) | 218 | 17 | 223 | 18 | 1,051 | 20 |
| Cash flows from operating activities | 195 | - | 222 | - | 966 | - |
(1) See "Adjusted EBITDA for the periods of activity" below.
| 1-3/2017 | 1-3/2016 | 2016 | |
|---|---|---|---|
| \$ millions | \$ millions | \$ millions | |
| Operating income (loss) | 116 | 107 | (3) |
| Capital loss (1) | - | 1 | 1 |
| Write-down and impairment of assets (2) | - | - | 489 |
| Provision for early retirement and dismissal of employees (3) | - | 6 | 39 |
| Provision in respect of prior periods resulting from an arbitration decision (4) | - | - | 13 |
| Retroactive electricity charges (5) | - | - | (16) |
| Provision for legal claims (6) | - | 1 | 8 |
| Provision for historical waste removal (7) | - | - | 51 |
| Total adjustments to operating income (loss) | - | 8 | 585 |
| Adjusted operating income | 116 | 115 | 582 |
| Net income (loss) attributable to the shareholders of the Company | 68 | 66 | (122) |
| Total adjustments to operating income (loss) | - | 8 | 585 |
| Adjustments to finance expenses (8) | - | - | 38 |
| Total tax impact of the above operating income & finance expenses adjustments | - | (2) | (81) |
| Tax assessment and deferred tax adjustments (9) | - | 13 | 36 |
| Adjustments attributable to the non-controlling interests | - | - | (5) |
| Total adjusted net income - shareholders of the Company | 68 | 85 | 451 |
Calculation of adjusted EBITDA was made as follows:
| 1-3/2017 | 1-3/2016 | 2016 | |
|---|---|---|---|
| \$ millions | \$ millions | \$ millions | |
| Net income (loss) attributable to the shareholders of the Company | 68 | 66 | (122) |
| Depreciation and amortization | 94 | 99 | 401 |
| Financing expenses, net | 14 | 28 | 132 |
| Taxes on income | 42 | 22 | 55 |
| Adjustments * | - | 8 | 585 |
| Total adjusted EBITDA | 218 | 223 | 1,051 |
We disclose in this Quarterly Report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the Company's shareholders and adjusted EBITDA. Our management uses adjusted operating income, adjusted net income attributable to the Company's shareholders and adjusted EBITDA to facilitate operating performance comparisons from period to period. We calculate our adjusted operating income by adjusting our operating income to add certain items, as set forth in the reconciliation table above. Certain of these items may recur. We calculate our adjusted net income attributable to the Company's shareholders by adjusting our net income attributable to the Company's shareholders to add certain items, as set forth in the reconciliation table above, excluding the total tax impact of such adjustments and adjustments attributable to the non-controlling interests. We calculate our adjusted EBITDA by adding back to the net income attributable to the Company's shareholders the depreciation and amortization, financing expenses, net, taxes on income and the items presented in the reconciliation table above which were adjusted for in calculating the adjusted operating income and adjusted net income attributable to the Company's shareholders.
You should not view adjusted operating income, adjusted net income attributable to the Company's shareholders or adjusted EBITDA as a substitute for operating income or net income attributable to the Company's shareholders determined in accordance with IFRS, and you should note that our definitions of adjusted operating income, adjusted net income attributable to the Company's shareholders and adjusted EBITDA may differ from those used by other companies. However, we believe adjusted operating income, adjusted net income attributable to the Company's shareholders and adjusted EBITDA provide useful information to both management and investors by excluding certain expenses that management believes are not indicative of our ongoing operations. Our management uses these non-IFRS measures to evaluate the Company's business strategies and management's performance. We believe that these non-IFRS measures provide useful information to investors because they improve the comparability of the financial results between periods and provide for greater transparency of key measures used to evaluate our performance.
We present a discussion in the period-to-period comparisons of the primary drivers of changes in the company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends in its businesses. We have based the following discussion on our financial statements. You should read the following discussion together with our financial statements.
Sales
| Sales analysis | \$ millions |
|---|---|
| Total sales Q1 2016 | 1,265 |
| Quantity | 115 |
| Price | (55) |
| Exchange rate | (30) |
| Total sales Q1 2017 | 1,295 |
Price the decrease derives mainly from a decline in the selling prices of phosphate fertilizers and phosphoric acid in ICL Phosphate, together with a decline in the selling prices of acids in ICL Advance Additives and a decline in potash selling prices.
Exchange rate – the decrease stems mainly from the devaluation of the euro and the Chinese yuan against the dollar.
The following table sets forth sales by geographical regions based on the location of the customer:
| 1-3/2017 | ||||
|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
|
| Europe | 534 | 41 | 559 | 44 |
| North America | 294 | 23 | 267 | 21 |
| Asia | 282 | 22 | 239 | 19 |
| South America | 98 | 8 | 92 | 7 |
| Rest of the world | 87 | 6 | 108 | 9 |
| Total | 1,295 | 100 | 1,265 | 100 |
The breakdown of the sales in the first quarter of 2017 shows a decrease in sales to Europe, stemming mainly from a decline in the selling prices of potash and phosphate products together with a decline in the quantities of phosphate rock sold. This decrease was partly offset by an increase in sales of ICL Industrial Products. The increase in sales to North America stems mainly from an increase in the quantities of potash and clear brines solutions sold, partly offset by a decrease in sales due to divestiture of non-core businesses last year. The increase in sales to Asia stems mainly from an increase in quantities sold of potash, phosphoric acid, bromine-based flame retardants and specialty agriculture products. The increase in sales to South America stems mainly from an increase in the quantities of phosphate fertilizers sold, partly offset by a decrease in potash quantities sold.
| Operating expenses analysis | \$ millions | ||
|---|---|---|---|
| Total operating expenses Q1 2016 | 1,158 | ||
| Quantity | 75 | ||
| Exchange rate | (20) | ||
| Raw materials Energy |
(25) - |
||
| Transportation | 20 | ||
| Other | (29) | ||
| Total operating expenses Q1 2017 | 1,179 |
The net financing expenses in the first quarter of 2017 amounted to \$14 million, compared with \$28 million in the corresponding quarter last year – a decrease of \$14 million. The decrease includes a decline of about \$16 million deriving mainly from an increase of the income in respect of the fair value of foreign currency hedging transactions, energy and marine shipping, net, partly offset by revaluation of the net liabilities, and a decrease in the interest expenses due to a decrease in the short term and long term debt. On the other hand, there was an increase in the financing expenses, in the amount of about \$2 million stemming mainly from exchange rate differences relating to provisions for employee benefits.
The tax expenses in the first quarter of 2017 amounted to \$42 million, compared with tax expenses of \$22 million in the corresponding quarter last year. The reported tax expenses in the current quarter were impacted mainly from tax expenses due to differences in the measurement base for tax purposes and the measurement base thereof for financial reporting purposes as a result of the strengthening of the Israeli shekel against the dollar. The effective tax rate, without the impact of the above-mentioned differences, is about 29%, compared with an effective tax rate of about 24%, in the corresponding quarter last year. The increase in the effective tax rate stems mainly from application of the Israeli Natural Resources Tax to the bromine and potash activities in Israel.
| 2 | 7 |
|---|---|
Segment revenues, expenses and results include inter-segment transfers, which are priced based on transaction prices in the ordinary course of business. These transfers are eliminated as part of consolidation of the financial statements. The segment income is measured based on the operating income, without certain expenses that are not allocated to the activity segments, including, general and administrative expenses, as it is included in reports that are regularly reviewed by the chief operating decision maker.
This segment includes three business lines: ICL Industrial Products, ICL Advanced Additives and ICL Food Specialties. The segment targets industrial markets and concentrates on achieving growth through a highly-tailored customer focus, product innovation and commercial excellence.
Total Advanced Additives performance was favorable compared to the corresponding quarter last year and was impacted by several factors:
x Sales volume of dairy proteins declined as a result of new local regulations for organic infant food in China, aimed at reducing the wide product portfolio currently available in the market in order to gain tighter control, and the subsequent destocking activity of a customer delivering proteins to China. Nevertheless, the general assessment of the Chinese infant food market remains positive and ICL Food Specialties was able to partially offset the decline through growth in other customer relationships existing in the growing Chinese market. First signs of recovery are expected during the second half of the year.
x ICL Food Specialties' phosphates business remained stable in the quarter as competitive pressure in North America and Europe was offset by a recovery in sales in Eastern Europe. The business line announced price increases in North America starting in the second quarter of 2017, with the full impact of the pricing adjustments expected to be realized beginning in the third quarter.
| 1-3/2017 | 1-3/2016 | 2016 \$ |
||
|---|---|---|---|---|
| \$ | \$ | |||
| millions | millions | millions | ||
| Industrial Products | 266 | 224 | 953 | |
| Sales to external customers | 264 | 223 | 946 | |
| Sales to internal customers | 2 | 1 | 7 | |
| Advanced Additives | 213 | 208 | 966 | |
| Sales to external customers | 199 | 188 | 897 | |
| Sales to internal customers | 14 | 20 | 69 | |
| Food Specialties | 138 | 162 | 659 | |
| Sales to external customers | 136 | 159 | 650 | |
| Sales to internal customers | 2 | 3 | 9 | |
| Setoffs | (4) | (10) | (25) | |
| Total segment sales | 613 | 584 | 2,553 | |
| Operating income | 115 | 106 | 534 | |
| Sales analysis | Industrial Products |
Advanced Additives |
Food Specialties |
Setoff | Segment Total |
|
|---|---|---|---|---|---|---|
| \$ millions | ||||||
| Total sales Q1 2016 | 224 | 208 | 162 | (10) | 584 | |
| Quantity | 50 | 20 | (20) | 5 | 55 | |
| Price | (5) | (10) | - | - | (15) | |
| Exchange rate | (3) | (5) | (4) | 1 | (11) | |
| Total sales Q1 2017 | 266 | 213 | 138 | (4) | 613 |
- Quantity – the increase derives mainly from an increase in clear brines solutions quantities sold together with brominebased flame retardants in ICL Industrial Products and from an increase in quantities sold in the P2S5 and acids subbusiness lines of ICL Advanced Additives. This increase was partly offset by the decrease in dairy protein quantities sold in ICL Food Specialties (which was slightly offset by an increase in quantities of new products sold). see also 'Significant highlights and business environment' section.
| Operating income analysis | \$ millions | ||
|---|---|---|---|
| Total operating income Q1 2016 | 106 | ||
| Quantity | 35 | ||
| Price | (15) | ||
| Exchange rate | (5) | ||
| Raw materials | 10 | ||
| Energy | - | ||
| Transportation | (1) | ||
| Other | (15) | ||
| Total operating income Q1 2017 | 115 |
Quantity – the increase stems mainly from the quantities of clear brines solutions and bromine-based flame retardants sold in ICL Industrial Products combined with P2S5 products in ICL Advanced Additives.
Price – the decrease stems mainly from lower selling prices of acids in ICL Advanced Additives and different products mix of clear brines solutions sold in ICL Industrial Products.
Exchange rate – the decrease stems mainly from devaluation of the euro against the dollar.
Raw materials – the increase stems mainly from a decrease in sulfur prices used for products of ICL Advanced Additives.
Other – the decrease derives, among others, from an increase in royalties paid as a result of the increase in sales.
- Price – the decrease stems mainly from different products mix of clear brines solutions sold in ICL Industrial products and a decrease in the selling prices of acids in ICL Advanced Additives.
This segment includes three business lines: ICL Potash & Magnesium, ICL Phosphate and ICL Specialty Fertilizers. The segment targets the Agro markets and focuses on efficiency, process innovation and operational excellence.
Business environment overview
consumption is being displaced as key sectors, such as primary aluminum and titanium production, are shifting to other markets, including Asia and Canada. The USA domestic producer, US Magnesium, is taking aggressive steps to offset the loss of the titanium producer, ATI (est. at 9,000 mt). US President, Mr. Donald Trump, announced a rollback of Current Corporate Average Fuel Economy (CAFE) standards, previously aimed at requiring automakers to achieve a fleet average of roughly 54.5 mpg by 2025. This follows the NHTSA's most recent postponement that would have delayed implementation of penalties until the 2019 model year. The concern is that this will slow the return of magnesium to the discussion among the automotive OEMs (original equipment manufacturers). New mileage standards and/or implementation deadlines have not been announced. Chinese price indicators continued moving lower during January falling from the peak of \$2,550 (November 1st), however recovered to \$2,300 per ton by early March. The current level represents a 24% increase above January 2016 prices. Support is in part being provided by higher ferrosilicon prices although this was partially offset by a domestic supply imbalance. Pure magnesium prices in the US market remain under pressure as a consequence of the aforementioned change in supply dynamics.
x Over-supply in the domestic market in China along with lower international prices continue to negatively affect the results of the YPH joint venture in China, which recorded negative operating income of \$6 million (not including G&A expenses) in the first quarter of 2017 (most of which relates to the ICL Phosphate business line). ICL is continuing its efforts to increase efficiency and reduce costs in a challenging market environment. Continued implementation of efficiency measures and acceleration of the shift to specialty products are expected to support the JV's profitability in the short and medium terms.
x The USA and Brazilian markets are showing good demand.
| 1-3/2017 | 1-3/2016 | 2016 \$ |
||
|---|---|---|---|---|
| \$ | \$ | |||
| millions | millions | millions | ||
| Potash & Magnesium | 283 | 273 | 1,338 | |
| Sales to external customers | 253 | 241 | 1,213 | |
| Sales to internal customers | 30 | 32 | 125 | |
| Phosphate | 292 | 299 | 1,163 | |
| Sales to external customers | 247 | 249 | 966 | |
| Sales to internal customers | 45 | 50 | 197 | |
| Specialty Fertilizers | 192 | 188 | 661 | |
| Sales to external customers | 186 | 180 | 632 | |
| Sales to internal customers | 6 | 8 | 29 | |
| Setoffs | (33) | (37) | (126) | |
| Total segment sales | 734 | 723 | 3,036 | |
| Operating income | 66 | 93 | 398 | |
For additional details regarding potash – see 'Potash – Stand-Alone Activities'.
| Sales analysis | Potash & Magnesium Phosphate |
Specialty Fertilizers |
Setoff | Segment Total |
||
|---|---|---|---|---|---|---|
| \$ millions | ||||||
| Total sales Q1 2016 | 273 | 299 | 188 | (37) | 723 | |
| Quantity | 25 | 35 | 15 | - | 75 | |
| Price | (5) | (35) | (5) | - | (45) | |
| Exchange rate | (10) | (7) | (6) | 4 | (19) | |
| Total sales Q1 2017 | 283 | 292 | 192 | (33) | 734 |
Quantity – the increase stems mainly from an increase in phosphoric acid and phosphate fertilizers quantities sold, together with an increase in potash sales (mainly in India and the USA) and from an increase in the quantities of specialty agriculture products sold.
Price – the decrease stems mainly from a decline in phosphate fertilizers and phosphoric acid selling prices, lower commodity fertilizers prices and a decline in potash selling prices.
Exchange rate – the decrease stems mainly from the devaluation of the euro and the Chinese yuan against the dollar.
| Operating income analysis | \$ millions | ||
|---|---|---|---|
| Total operating income Q1 2016 | 93 | ||
| Quantity | 10 | ||
| Price | (45) | ||
| Exchange rate | (5) | ||
| Raw materials | 20 | ||
| Energy | - | ||
| Transportation | (20) | ||
| Other | 13 | ||
| Total operating income Q1 2017 | 66 |
Quantity – the increase derives mainly from the quantities of potash and specialty agriculture products sold.
Price the decrease stems mainly from a decline in phosphate fertilizers and phosphoric acid selling prices, lower commodity fertilizers prices and a decline in potash selling prices.
| 1-3/2017 | 1-3/2016 | 2016 |
|---|---|---|
| 5,744 | ||
| 1,032 | ||
| 4,099 | ||
| 2,725 | ||
| 649 | 506 | 2,645 |
| 1,400 160 1,096 570 |
1,341 362 751 573 |
* To external customers.
The quantity of fertilizers sold in the first quarter of 2017 was 143 thousand tonnes higher than in the corresponding quarter last year. The increase stems mainly from an increase in sales to Brazil and to China (by the YPH joint venture). In the first quarter of 2017, manufacture of phosphate fertilizers was lower by 3 thousand tonnes. The quantity of phosphate rock sold in the first quarter decreased significantly due to increased internal use for fertilizer production in China, as well as low global demand and an unattractive prices environment.The production of phosphate rock was higher by 59 thousand tonnes mainly due to increased production in ICL Rotem in Israel.
| Millions of dollars | 1-3/2017 | 1-3/2016 | 2016 |
|---|---|---|---|
| Average potash selling price - FOB (in \$) | 216 | 235 | 211 |
| Sales to external customers | 231 | 221 | 1,134 |
| Sales to internal customers * | 36 | 40 | 151 |
| Operating income | 41 | 51 | 291 |
* Sales to other business lines of ICL including the Magnesium business.
The potash stand-alone activities include, among others, Polysulphate ™ produced in a mine in the UK and salt produced in underground mines in UK and Spain.
| Sales analysis | \$ millions |
|---|---|
| Total sales Q1 2016 | 261 |
| Quantity | 20 |
| Price | (5) |
| Exchange rate | (9) |
| Total sales Q1 2017 | 267 |
| Operating income analysis | \$ millions | |
|---|---|---|
| Total operating income Q1 2016 | 51 | |
| Quantity | 5 | |
| Price | (5) | |
| Exchange rate | - | |
| Raw materials and energy | - | |
| Transportation | (15) | |
| Other | 5 | |
| Total operating income Q1 2017 | 41 |
Quantity – the increase derives mainly from potash sales in India and the USA.
Price – the decrease stems from a decline in potash selling prices.
Transportation – the decrease stems mainly from an increase in transportation prices and an increase in quantities of potash sold.
| Thousands of Tonnes | 1-3/2017 | 1-3/2016 | 2016 | |
|---|---|---|---|---|
| Production | 1,057 | 1,348 | 5,279 | |
| Sales to external customers | 942 | 893 | 4,818 | |
| Sales to internal customers | 72 | 24 | 347 | |
| Total sales (including internal sales) | 1,014 | 917 | 5,165 | |
| Closing inventory | 709 | 983 | 666 |
The quantity of potash sold to external customers in the first quarter of 2017, was 49 thousand tonnes higher than in the corresponding quarter last year, mainly due to an increase in sales to India and the USA. Production of potash in the first quarter of 2017 was 291 thousand tonnes lower than in the corresponding quarter last year, due to a decrease in the production of ICL UK as a result of operational breakdown in the mine tailings channel. The production was renewed at the beginning of the second quarter of 2017, and in the Company's estimation the under-production will be made up during the course of the year.
In the first quarter of 2017, the cash flows provided by operating activities decreased by \$27 million compared with the corresponding quarter last year. This decrease stems mainly from a decline in the trade receivables in the corresponding quarter last year due to a collection of extensive sales in the end of 2015. The said decrease was partly offset due to a decrease in the production of ICL UK as a result of operational breakdown in the mine tailings channel.
In the first quarter of 2017, the cash flows used in investing activities decreased compared with the corresponding quarter last year, by \$319 million. This decrease stems mainly due to payment for acquisition of 15% of the shares of YTH, in the amount of about \$250 million, in the corresponding quarter last year. In addition, there was a decline in the cash flows used for investments in property, plant and equipment, in the amount of \$81 million.
In the first quarter of 2017, there was an increase of \$258 million in the cash flows used in financing activities compared with the corresponding quarter last year. This increase stems mainly from repayment of long-term loans net of long-term loans received, in the amount of \$155 million, repayment of short-term credit from banks and others, net, in the amount of \$43 million and timing differences relating to a dividend payment in the amount of \$60 million.
As at March 31, 2017, the net financial liabilities of ICL amounted to \$3,262 million, a decrease of \$6 million compared with the balance at the end of 2016. The decrease of the net financial liabilities stems mostly from the operating cash flow generated during the quarter which was offset by a dividend payment of \$60 million.
The total amount of the securitization framework and credit facility deriving therefrom amounts to \$405 million. As at March 31, 2017, ICL had used \$312 million of the securitization facility.
ICL also has long-term credit facilities of \$2,026 million and €100 million, of which \$1,284 million was unused as at March 31, 2017.
On March 23, 2017, Fitch Ratings lowered the Company's international corporate credit rating to BBB– with a stable rating outlook. Fitch's above-mentioned rating also applies to the Company's debentures. According to the Company's estimate, the impact of the said rating reduction on its financial expenses, if any, will be negligible.
As the date of the report, the Company is in compliance with the financial covenants stipulated in its financing agreements.
There were no material changes in our critical accounting estimates during the three-month period ended March 31, 2017.
Commencing from February 1, 2017, Mr. Eli Glazer, formerly the CEO of ICL Europe, is serving as the President of ICL Specialty Solutions, in place of Mr. Mark Volmer, who concluded his position on January 31, 2017.
On March 14, 2017, the Company's Board of Directors approved the appointment of Mr. Reem Aminoach as a member of the Company's Board of Directors. Mr. Aminoach's service will be valid up to the next General Meeting of the Company's shareholders.
On March 31, 2017, Mr. Nissim Adar, concluded his position as the President of ICL Essential Minerals. Commencing from April 1, 2017, Mr. Ofer Lifshitz, who up to recently headed ICL's efficiency and cash-flow improvement program, replaced Mr. Adar as the President of ICL Essential Minerals.
In the three-month period ended March 31, 2017, there were no material changes in the risk factors previously disclosed in our Annual Report on Form 20-F for the year ended December 31, 2016.
Reference is made to "Item 11 – Quantitative and Qualitative Disclosures about Market Risks" in our Annual Report on Form 20-F for the year ended December 31, 2016.
Pursuant to ICL's Board resolution dated December 15, 2016, the Company has appointed a special independent external committee (the "Special Committee") to examine all of the aspects arising from the application for certification of a derivative action regarding the annual bonuses paid to office holders for the years 2014-2015 (the "Certification Application"). The Special Committee was headed by Hon. Justice (ret.) Oded Mudrick, and the other members therein were: Prof. Sharon Hannes and Prof. Haim Assayag, CPA. For purposes of its operations, the Special Committee appointed a legal advisor to accompany its work – Dr. Asaf Eckstein.
On April 18, 2017, the Special Committee submitted its report to the Board of Directors, wherein it determined, among other things, that in its opinion the adjustments to the net profit as approved by the Company's Compensation Committee for the years 2014 and 2015 were duly made and in accordance with the Company's Compensation Policy. Therefore, the Company does not have a cause of action against the directors who approved the bonus adjustments for the years 2014 and 2015, or against the officers who received the bonuses due to the said adjustments. In light of the foregoing, it would be improper for the Company to demand any restitution or reparation due to the events specified in the Certification Application filed by the Applicant. Accordingly, the Committee recommended that the Company oppose the Application filed with the Court by the Applicant.
In its meeting on April 26, 2017, the Board resolved to fully adopt the Special Committee's report and the recommendation therein to deny the Applicant's demand in the Certification Application and to instruct the Company to file an objection to the Certification Application.
Further to Note 13 of the 2016 annual financial statements, a Company subsidiary, ICL Europe, plans to file an investment treaty claim against the Federal Democratic Republic of Ethiopia ("Ethiopia") in relation to State violations of the Agreement on Encouragement and Reciprocal Protection of Investments between Ethiopia and the Netherlands (the Ethiopia-Netherlands BIT). The violations relate to, inter alia, the State's imposition of an illegal tax assessment against, and its failure to provide infrastructure support to, Allana Potash Afar Plc, an indirect subsidiary of ICL Europe . ICL Europe plans to file the claim under the Arbitration Rules of the United Nations Commission on International Trade Law (UNCITRAL), and requested that the Permanent Court of Arbitration at The Hague administer the arbitration proceedings. As at the date of the report, the Company has booked a full tax provision in respect of the tax assessment.
For further information regarding legal proceedings and other contingencies, see Note 6 to the Company's condensed consolidated interim financial statements as at March 31, 2017.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| By: | /s/ Kobi Altman | ||
|---|---|---|---|
| Name: Title: |
Kobi Altman Chief Financial Officer |
By: /s/ Lisa Haimovitz
Name: Lisa Haimovitz Title: Senior Vice President, Global General Counsel and Corporate Secretary
Date: May 10, 2017
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.